
AVI Photochem Q1 Results FY27: Net Loss of Rs 18 Lakh for June 2026 Quarter
AVI Photochem Q1 results FY27: Net Loss Rs 18 Lakh (+54.92% YoY) | Revenue Rs 0 Cr (-100.00% YoY) | Stock Rs 49.91 (flat 0.00%)
Updated: 6 Aug 2026 • 10:45 am
Posted by:

The AVI Photochem Q1 results FY27 show standalone revenue of Rs 0 Cr for the quarter ended 30 June 2026, -100.00% year on year from Rs 0.58 Cr in Q1 FY26, as AVI Photochem reported its numbers on 6 August 2026. AVI Photochem posted net loss of a net loss of Rs 0.18 Cr for the quarter, against a net loss of Rs 0.4 Cr in Q1 FY26, a change of +54.92%. Shares traded around Rs 49.91 on the NSE, flat 0.00% on the day.
The specialty chemicals sector is emerging from a two-year destocking downcycle. Agrochemicals in particular have faced demand pressure from channel inventory correction and Chinese competition on pricing. Revenue per kilogram and EBITDA margin recovery are the two metrics that determine when the cycle turns. Against that backdrop, the AVI Photochem Q1 results FY27 give investors the first hard data point for FY27. This article breaks down what happened at the revenue, gross profit, and net profit line, what the numbers mean for the full year, and what questions investors should be asking before making any portfolio decision.
Click Here – Get Free Investment Predictions
AVI Photochem Q1 results FY27 Financial Highlights
All figures are standalone numbers in Rs Crore as reported by AVI Photochem for Q1 FY27 (April to June 2026). The table compares them against the same quarter in FY26.
| Metric | Q1 FY27 (Jun 2026) | Q1 FY26 (Jun 2025) | YoY Change |
|---|---|---|---|
| Revenue | Rs 0 Cr | Rs 0.58 Cr | -100.00% |
| Gross Profit | (Rs 0.28 Cr) | (Rs 0.42 Cr) | +34.35% |
| Gross Profit Margin | NA | -72.4% | NA |
| Net Profit (PAT) | (Rs 0.18 Cr) | (Rs 0.4 Cr) | +54.92% |
| Net Profit Margin | NA | -69.0% | NA |
AVI Photochem Q1 results FY27 Performance Analysis
Revenue contracted this quarter, the most visible headwind in the numbers. AVI Photochem reported Rs 0 Cr, down -100.00% from Rs 0.58 Cr in Q1 FY26. Investors will want to understand whether this is a cyclical correction, a volume/mix issue, or something more structural.
Operating profitability showed positive momentum this quarter. Gross profit grew +34.35% to a gross loss of Rs 0.28 Cr from a gross loss of Rs 0.42 Cr a year earlier, outpacing revenue growth and signalling cost discipline or a favourable product mix.
Loss reduction was the key positive in the results. Net loss improved to a net loss of Rs 0.18 Cr from a net loss of Rs 0.4 Cr a year ago. The pace of loss reduction will be the primary metric analysts use to update their profitability timelines for AVI Photochem.
Check the Univest Screener for Live Data
AVI Photochem Q1 results FY27: Key Business Factors
1. Revenue: What Drove the Quarter
AVI Photochem reported revenue of Rs 0 Cr for the June 2026 quarter, down -100.00% from Rs 0.58 Cr in Q1 FY26. A revenue decline in the specialty chemicals sector can reflect channel destocking, a strategic exit from low-margin business, or genuine demand weakness. Management's explanation on the earnings call will determine how investors reprice the stock. Investors should distinguish between structural decline and a one-quarter correction before drawing conclusions from the AVI Photochem Q1 results FY27.
2. Gross Profit and Margin Trends
Gross profit for the quarter was a gross loss of Rs 0.28 Cr. A detailed margin analysis is limited by the year-ago base, but the absolute gross profit figure is the foundation from which AVI Photochem covers its fixed costs and generates net profit. In the specialty chemicals sector, raw material price volatility, energy costs and demand cyclicality in end user industries are the primary inputs to watch.
3. Net Profit and Earnings Quality
AVI Photochem posted net loss of a net loss of Rs 0.18 Cr for the June 2026 quarter, against a net loss of Rs 0.4 Cr in Q1 FY26, a change of +54.92%. This bottom line figure is what drives earnings per share and, ultimately, the P/E multiple at which the stock trades. Analysts will now update their FY27 EPS estimates using this Q1 run rate, adjusted for any seasonal factors and guidance management provides on the earnings call.
AVI Photochem Q1 results FY27 vs Analyst Expectations
Whether the AVI Photochem Q1 results FY27 met, beat, or missed analyst forecasts will determine how quickly institutional investors reposition their holdings.
Analyst estimates for the AVI Photochem Q1 results FY27 varied ahead of the announcement. The actual revenue of Rs 0 Cr and net loss of a net loss of Rs 0.18 Cr now set the benchmark against which FY27 consensus estimates will be revised. When a company beats on both revenue and profit, the stock typically sees buying in the first post-result session. A miss on both tends to trigger selling and downgrades. A mixed print stays range-bound until the earnings call provides clarity. Investors tracking AVI Photochem should check live analyst verdict updates on the Univest Screener alongside the stock price movement to contextualise the post-result market reaction.
AVI Photochem Dividend Update
Investors tracking dividend history alongside the AVI Photochem Q1 results FY27 should note that payout ratios are typically decided at the annual board meeting.
No specific dividend announcement was confirmed as part of the AVI Photochem Q1 results FY27 snapshot. Most companies declare dividends at the annual board meeting rather than with quarterly results. Investors tracking AVI Photochem for its dividend yield should check the official NSE or BSE exchange filing, or the Univest Screener, for the latest record date and payout details.
AVI Photochem Outlook After Q1 results FY27
The AVI Photochem Q1 results FY27 establish the Q1 FY27 baseline for revenue at Rs 0 Cr and net loss at a net loss of Rs 0.18 Cr. Whether FY27 ends up as a year of acceleration depends on two variables: whether the decline in revenue sustains through Q2 to Q4, and whether margin trends improve, stabilise, or deteriorate relative to this quarter's gross profit margin of the levels reported this quarter. Management guidance on the earnings call will be the single most important datapoint for updating FY27 forecasts. Investors should also track macroeconomic inputs relevant to the specialty chemicals sector through the rest of the year.
Investors tracking AVI Photochem after the Q1 FY27 numbers should focus on three things heading into Q2 FY27: whether the decline in revenue sustains, whether the narrowing loss trend in profit continues without the help of one-off items, and whether management's guidance for FY27 holds. A results conference call or investor presentation, if scheduled, will be the primary opportunity for management to address these questions.
Should You Buy AVI Photochem After the Q1 results FY27?
The question most investors ask after any quarterly result is whether it changes the investment case. The AVI Photochem Q1 results FY27 show revenue of Rs 0 Cr, gross profit of a gross loss of Rs 0.28 Cr, and net loss of a net loss of Rs 0.18 Cr. Whether these numbers justify buying, holding, or selling depends on the price the stock is trading at (Rs 49.91 at the time of this result), the FY27 consensus earnings estimate, and whether this Q1 run rate is sustainable for the remaining three quarters. Investors should check the P/E, P/B, and EV/EBITDA multiples on the Univest Screener against sector peers before deciding. This article is for educational purposes only and does not constitute investment advice. Please consult a SEBI-registered investment advisor before making any investment decision.
AVI Photochem Share Price After the Q1 results FY27
AVI Photochem shares traded at Rs 49.91 on the NSE, flat 0.00% on the day the AVI Photochem Q1 results FY27 were in focus. Post-result price moves are often driven by event-driven traders who have built positions ahead of the result and unwind them regardless of outcome. Investors should look past the first-session move and focus on whether the fundamental trend in revenue and earnings has changed. The 52 week high, 52 week low, and technical support levels for AVI Photochem are available on the Univest Screener for investors who want to time their entry or exit.
Download the Univest iOS App or Univest Android App to track AVI Photochem live share price and upcoming quarterly results.
Key Risks to Track After the AVI Photochem Q1 results FY27
Investors should weigh these risks carefully before acting on the Q1 data.
1. Sector and Margin Risk
AVI Photochem operates in the specialty chemicals sector, which is exposed to raw material price volatility, energy costs and demand cyclicality in end user industries. A reversal of the trends visible in the AVI Photochem Q1 results FY27, particularly on the gross profit margin, could put the full-year FY27 earnings estimate at risk.
2. Single-Quarter vs Trend Risk
A single quarterly result can be distorted by working capital cycles, timing of receivables, or one-off costs and reversals that do not repeat. The AVI Photochem Q1 results FY27 should be read alongside Q2 data before drawing firm conclusions.
3. Macro and External Risk
Macro factors including RBI rate decisions, INR/USD movements, input commodity prices, and rural versus urban demand mix can shift the environment in the specialty chemicals sector faster than company-level actions can compensate for.
Conclusion
Investors researching the AVI Photochem Q1 results FY27 will find the key numbers, revenue, gross profit, and net profit, summarised in the table above and analysed in each section of this article.
The AVI Photochem Q1 results FY27 show standalone revenue of Rs 0 Cr (-100.00% year on year) and net loss of a net loss of Rs 0.18 Cr (versus a net loss of Rs 0.4 Cr in Q1 FY26). Gross profit came in at a gross loss of Rs 0.28 Cr, improving from a gross loss of Rs 0.42 Cr a year earlier. A revenue decline and a narrower net loss were the two key themes of the quarter. Investors tracking AVI Photochem should use the AVI Photochem Q1 results FY27 as the baseline and watch Q2 FY27 results, due around October 2026, as the first confirmation of whether these trends are durable. Always consult a SEBI-registered advisor before acting on any quarterly result.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on AVI Photochem Q1 results FY27
What were the AVI Photochem Q1 results FY27?
Ans. AVI Photochem reported revenue of Rs 0 Cr (-100.00% YoY) and net loss of a net loss of Rs 0.18 Cr for Q1 FY27 (quarter ended 30 June 2026), against a net loss of Rs 0.4 Cr in Q1 FY26.
What is the PAT in the AVI Photochem Q1 results FY27?
Ans. Net loss in the AVI Photochem Q1 results FY27 stood at a net loss of Rs 0.18 Cr, compared with a net loss of Rs 0.4 Cr in Q1 FY26, a change of +54.92%.
What was the revenue in the AVI Photochem Q1 results FY27?
Ans. Revenue in the AVI Photochem Q1 results FY27 was Rs 0 Cr, a change of -100.00% from Rs 0.58 Cr in Q1 FY26.
What was the gross profit in the AVI Photochem Q1 results FY27?
Ans. Gross profit in the AVI Photochem Q1 results FY27 was a gross loss of Rs 0.28 Cr, compared with a gross loss of Rs 0.42 Cr in Q1 FY26, a change of +34.35%.
Did AVI Photochem declare a dividend with the Q1 results FY27?
Ans. No dividend was confirmed as part of the AVI Photochem Q1 results FY27 snapshot. Check the NSE or BSE exchange filing for the latest dividend announcement from AVI Photochem.
What is the outlook for AVI Photochem after Q1 results FY27?
Ans. Following the AVI Photochem Q1 results FY27, analysts will track whether the decline in revenue and narrowing loss in profit continue into Q2 FY27 (September quarter), along with margin trends and management guidance.
Is AVI Photochem a good buy after Q1 results FY27?
Ans. The AVI Photochem Q1 results FY27 show revenue of Rs 0 Cr and net loss of a net loss of Rs 0.18 Cr. Investment decisions should be based on valuation relative to earnings trajectory, not a single quarter. Consult a SEBI-registered advisor before investing.
Recent Articles

Varroc Engineering Ltd. (VARROC) Share Price Hits Fresh 52-Week High
6 August 2026

Sterling Tools Q1 Results FY27: PAT at Rs 5 Cr for June 2026 Quarter
6 August 2026

Sarla Performance Fibers Q1 Results FY27: PAT at Rs 37 Cr for June 2026 Quarter
6 August 2026

Sky Gold Ltd. (SKYGOLD) Share Price Hits Fresh 52-Week High
6 August 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Varroc Engineering Ltd. (VARROC) Share Price Hits Fresh 52-Week High
Sterling Tools Q1 Results FY27: PAT at Rs 5 Cr for June 2026 Quarter
Sarla Performance Fibers Q1 Results FY27: PAT at Rs 37 Cr for June 2026 Quarter
Sky Gold Ltd. (SKYGOLD) Share Price Hits Fresh 52-Week High
Cohance Lifesciences Q1 Results FY27: Net Loss of Rs 45 Cr for June 2026 Quarter
Popular this week
Varroc Engineering Ltd. (VARROC) Share Price Hits Fresh 52-Week High
Sterling Tools Q1 Results FY27: PAT at Rs 5 Cr for June 2026 Quarter
Sarla Performance Fibers Q1 Results FY27: PAT at Rs 37 Cr for June 2026 Quarter
Sky Gold Ltd. (SKYGOLD) Share Price Hits Fresh 52-Week High
Cohance Lifesciences Q1 Results FY27: Net Loss of Rs 45 Cr for June 2026 Quarter

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





